4,5-Diaryl-3-aminopyrazole derivatives as analogs of Combretastatin A-4: synthesis and biological evaluation

Arch Pharm (Weinheim). 2011 May;344(5):279-86. doi: 10.1002/ardp.201000069. Epub 2011 Feb 2.

Abstract

A series of cis-restricted 4,5-diaryl-3-aminopyrazole derivatives were synthesized and tested for their cytotoxic activity in vitro against five human cancer cell lines (K562, ECA-109, A549, SMMC-7721, and PC-3). Compounds 5a, 5b, 5d, and 6b showed potent cytotoxicity against all tested cell lines. Primary mechanism research on compound 5a indicated that it was a potent inhibitor of tubulin polymerization, arresting cell cycle in G(2)/M phase. The docking research showed the conformation of 5a overlaps well with CA-4 in the crystallized protein complex, suggesting the 4,5-diaryl-3-aminopyrazoles were good mimics of CA-4.

MeSH terms

  • Antineoplastic Agents, Phytogenic / chemical synthesis*
  • Antineoplastic Agents, Phytogenic / chemistry
  • Antineoplastic Agents, Phytogenic / metabolism
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Binding Sites
  • Cell Cycle / drug effects*
  • Cell Division / drug effects*
  • Cell Line, Tumor
  • Humans
  • Polymerization / drug effects
  • Pyrazoles / chemical synthesis*
  • Pyrazoles / chemistry
  • Pyrazoles / metabolism
  • Pyrazoles / pharmacology*
  • Stilbenes / chemistry*
  • Tubulin / chemistry*
  • Tubulin / metabolism

Substances

  • Antineoplastic Agents, Phytogenic
  • Pyrazoles
  • Stilbenes
  • Tubulin
  • fosbretabulin